Difference between revisions of "ANLY482 AY2016-17 T2 Group10"

From Analytics Practicum
Jump to navigation Jump to search
Line 34: Line 34:
 
<!-- Body - Introduction -->
 
<!-- Body - Introduction -->
 
==<div style="background: #ffffff; padding: 17px;padding:0.3em; letter-spacing:0.1em; line-height: 0.1em;  text-indent: 10px; font-size:17px; text-transform:uppercase; font-weight: light; font-family: 'Century Gothic';  border-left:8px solid #1b96fe"><font color= #000000><strong>Introduction</strong></font></div>==
 
==<div style="background: #ffffff; padding: 17px;padding:0.3em; letter-spacing:0.1em; line-height: 0.1em;  text-indent: 10px; font-size:17px; text-transform:uppercase; font-weight: light; font-family: 'Century Gothic';  border-left:8px solid #1b96fe"><font color= #000000><strong>Introduction</strong></font></div>==
−
<div style="margin:0px; padding: 10px; background: #f2f4f4; font-family: Century Gothic, Open Sans, Arial, sans-serif; border-radius: 7px; text-align:left">
+
<div style="margin:0px; padding: 10px; background: #f2f4f4; font-family: Century Gothic, Open Sans, Arial, sans-serif; border-radius: 7px; text-align:left;font-size:15px">
−
 
+
GlaxoSmithKline (GSK) is a British pharmaceutical company focusing on manufacturing products for illnesses such as asthma, cancer, infections, diabetes and mental health that come in the form of medicines, vaccines and other various consumer health products. This project aims to understand the consumer purchasing patterns and behaviour within Singapore and at the same time, evaluate the effectiveness of different sales and marketing strategies within different areas of Singapore.  
−
Lorem ipsum dolor sit amet, pri in debet primis delenit, eos ne quas doctus. Ei mea semper erroribus forensibus, pro sint hendrerit ne, ius ne decore omittam. At quot facilisi consequat pro. Delenit reformidans et usu, bonorum facilisi similique ne sed. Usu epicurei recteque id.
 
−
 
 
−
Eum accusam phaedrum eu, dicat phaedrum mei ex. Inani tation accommodare vel ut, consul petentium in ius, odio mazim iusto per et. Cum purto nusquam civibus id, timeam aliquip est ex. Eam volumus voluptatibus ex. Sale nihil commodo ut quo. Ad porro eripuit nec, et veri possim graecis vix.
 
−
 
 
−
Assum reformidans at cum, ei eius definitiones ius, pri aeque regione te. Pro autem dicat phaedrum ut, pro dico augue facete ex, errem fabulas interesset ei vel. Id sed ornatus minimum accumsan, option maiorum intellegat et nam, ad sea impetus sanctus assueverit. At quod abhorreant pro. Te pro noster imperdiet democritum.
 
−
 
 
−
Dicant scripserit has id, est error audiam et, ea eos labitur fierent molestie. Odio scriptorem cum ut, eu qui probo elitr, idque scripta sea ad. Mel ei omnesque complectitur. Vim at assum dicant nostro, quod alia dissentias ut est, sed eu liber aeterno. Sea essent efficiendi eu, vel graecis appetere an.
 
−
 
 
−
Mel sonet virtute te, ad agam sale ludus vim. In nostrud periculis usu. Ut eum epicurei mediocritatem, nullam corpora delectus ei quo. His id facete quodsi. Ius ei altera consectetuer, viderer molestie fabellas quo ea, iudico oratio oportere duo ad. Et pri sint velit scripserit, ullum quaestio voluptaria sed ad. Minim munere reformidans has ut, has dicit primis integre ea, esse inani definiebas ea per.
 
 
</div>
 
</div>
  
Line 52: Line 43:
 
<!-- Body - Project Progress -->
 
<!-- Body - Project Progress -->
 
==<div style="background: #ffffff; padding: 17px;padding:0.3em; letter-spacing:0.1em; line-height: 0.1em;  text-indent: 10px; font-size:17px; text-transform:uppercase; font-weight: light; font-family: 'Century Gothic';  border-left:8px solid #1b96fe"><font color= #000000><strong>Project Progress</strong></font></div>==
 
==<div style="background: #ffffff; padding: 17px;padding:0.3em; letter-spacing:0.1em; line-height: 0.1em;  text-indent: 10px; font-size:17px; text-transform:uppercase; font-weight: light; font-family: 'Century Gothic';  border-left:8px solid #1b96fe"><font color= #000000><strong>Project Progress</strong></font></div>==
−
<div style="margin:0px; padding: 10px; background: #f2f4f4; font-family: Century Gothic, Open Sans, Arial, sans-serif; border-radius: 7px; text-align:left">
+
<div style="margin:0px; padding: 10px; background: #f2f4f4; font-family: Century Gothic, Open Sans, Arial, sans-serif; border-radius: 7px; text-align:left;font-size:15px">
 
* <strong>Project Completion Status</strong>
 
* <strong>Project Completion Status</strong>
−
 
+
{{Progress bar|10}}
 
</div>
 
</div>
  
 
<!-- End Body --->
 
<!-- End Body --->

Revision as of 23:17, 15 January 2017

Kesmyjxlogo.png

HOME

ABOUT US

PROJECT OVERVIEW

ANALYSIS & FINDINGS

PROJECT MANAGEMENT

DOCUMENTATION

<< ANLY482 AY2016-17 T2 Projects

Introduction

GlaxoSmithKline (GSK) is a British pharmaceutical company focusing on manufacturing products for illnesses such as asthma, cancer, infections, diabetes and mental health that come in the form of medicines, vaccines and other various consumer health products. This project aims to understand the consumer purchasing patterns and behaviour within Singapore and at the same time, evaluate the effectiveness of different sales and marketing strategies within different areas of Singapore.


Project Progress

  • Project Completion Status

10% completed (estimate)

   


Retrieved from ‘https://wiki.smu.edu.sg/ANLY482/index.php?title=ANLY482_AY2016-17_T2_Group10&oldid=12774’